0001209191-24-001302.txt : 20240109 0001209191-24-001302.hdr.sgml : 20240109 20240109193528 ACCESSION NUMBER: 0001209191-24-001302 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240105 FILED AS OF DATE: 20240109 DATE AS OF CHANGE: 20240109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shukla Sanjay CENTRAL INDEX KEY: 0001671026 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 24524583 MAIL ADDRESS: STREET 1: C/O ATYR PHARMA, INC. STREET 2: 10240 SORRENTO VALLEY ROAD, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 203435077 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8587318389 MAIL ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-05 0 0001339970 aTYR PHARMA INC LIFE 0001671026 Shukla Sanjay 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 1 1 0 0 President and CEO 0 Employee Stock Option (right to buy) 1.50 2024-01-05 4 A 0 600000 0.00 A 2034-01-05 Common Stock 600000 600000 D The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. /s/ Nancy E. Denyes, attorney-in-fact 2024-01-09